A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death-Reference-Cited by-同舟云学术

A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death

Published:2020-01-25 Issue:3 Volume:13 Page:529-538
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Briand François¹,Heymes Christophe²,Bonada Lucile¹,Angles Thibault²,Charpentier Julie²,Branchereau Maxime²,Brousseau Emmanuel¹,Quinsat Marjolaine¹,Fazilleau Nicolas³,Burcelin Rémy²,Sulpice Thierry¹

Affiliation:

1. Physiogenex Escalquens France

2. Inserm U1048 CHU Rangueil Toulouse Cedex 4 France

3. Inserm CPTP‐U1043 CHU Purpan Toulouse Cedex 3 France

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12735

Reference37 articles.

1. Non-alcoholic fatty liver disease – A global public health perspective

2. Molecular pathogenesis of nonalcoholic steatohepatitis‐ (NASH‐) related hepatocellular carcinoma;Kutlu O.;Can. J. Gastroenterol. Hepatol.,2018

3. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges

4. Mechanisms of NAFLD development and therapeutic strategies

5. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cell death in NAFLD: mechanisms and targeted therapies;Cell Death Discovery;2024-09-07

2. An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD;Hepatology Communications;2024-05

3. Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions;World Journal of Gastroenterology;2024-04-14

4. High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats;Physiological Research;2023-06-30

5. Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines;Hepatology;2023-01-03